Search
for
Sort by
Research 30 of 1000+
- Cultural Sensitivity and Challenges in Management of the Transgender Patient With ESRD in Transplantation
- Hormone-related hair disorders - from clinical needs to new therapeutic perspectives
- Sex Hormones and Hair Loss in Men From the General Population of Northeastern Germany.
- Hair loss evolving into a lifestyle and metabolic phenotype: A hypothesis exploring oxidative stress and acquired androgen sensitivity through reactive oxygen species
- The role of glypican-4, thyroid stimulating hormone, and reproductive hormones in polycystic ovary syndrome progress among Iraqi women
- A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Tissue insulin sensitivity and body weight in polycystic ovary syndrome
- Lack of Significant Association between Sex Hormone Concentrations and Atopic Dermatitis in Adolescents and Adults in Two Population-Based Studies
- Effects of Exercise Combined with Finasteride on Hormone and Ovarian Function in Polycystic Ovary Syndrome Rats
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management
- Chapter 7 Reproductive Dysfunction in Women with Epilepsy
- The relationship among androgens, insulin resistanceand ghrelin polymorphisms in post-adolescent malepatients with severe acne vulgaris
- MEDICINAL PLANTS USED IN THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME (PCOD)
- Green Tea as a Supportive Therapy for PCOS: Evaluating Its Impact on Symptom Relief
- Silencing Inflammation: Nano-Antioxidants and Immunomodulators in PCOS Management
- Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”
- A Review of Hair Anatomy and Animal Models for Alopecia
- Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
- Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
- The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research
- A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome
- Development and evaluation of novel rodent model of PCOS mimicking clinical phenotype in human disease
- Androgenic modulation of arterial baroreceptor dysfunction and neuroinflammation in endotoxic male rats
- Protective Effect of “ <i>Ark‐e‐Kasni</i> ,” a Unani Formulation, in Letrozole and High‐Fat Diet–Induced Polycystic Ovarian Syndrome in Rats
- Metformin in the Treatment of Polycystic Ovary Syndrome: A Literature Review
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007
- Pituitary Effects of Metformin in Men With Early‐Onset Androgenic Alopecia